Fusion protein to target and treat acute myeloid leukemia cells
US10072093B2 · kind B2 · utility
0Cited by
5References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 4, 2014 |
| Grant date | Sep 11, 2018 |
| Priority date | — |
| Expiry date | Jul 4, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y204/02036
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A polypeptide which binds to the surface of AML blast cells and is internalized upon binding to the AML blast cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.